# Buzzreach

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/buzzreach

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.buzzreach.co.jp
- Total disclosed funding: $7.1M
- Latest round: Series A (May 17, 2023)
- Investors on record: 4

## About

Founded in 2017 and based in Tokyo, Japan, Buzzreach Inc. operates as a provider of puzz a SaaS-based management system, FeasiCon, Study Works, and many other services to support clinical trials and research. In May 2024, the firm raised an amount in venture funding from new investor Sumisho Venture Partners. As of 2024, the company is headed by its CEO Takateru Inokawa.

Buzzreach offers a range of services designed to support and optimize clinical research. Key products include the "StudyWorks" platform for resolving clinical research challenges, the "Miraiku" patient SNS, and COVID-19 cohort research initiatives. These products utilize technology to facilitate feasibility, project management, and patient engagement in clinical trials.

The company plans to use the May 2024 funds to leverage its network and expertise to create new businesses in CRO and data application, aligning with the DCT trend, to support Buzzreach's mission of providing new options to patients through technology.

## Funding rounds

- Series A, May 17, 2023, $1.8M — Aozora Corporate Investment
- Series A, Jul 21, 2022, $4.8M — Globis Capital Partners, Mobile Internet Capital, ANOBAKA
- Seed, Mar 5, 2019, $0.5M — ANOBAKA

## Investors

- ANOBAKA (https://capitalatlas.ai/funds/anobaka) — Seed, Series A
- Globis Capital Partners (https://capitalatlas.ai/funds/globis-capital-partners) — Series A
- Mobile Internet Capital (https://capitalatlas.ai/funds/mobile-internet-capital) — Series A
- Aozora Corporate Investment (https://capitalatlas.ai/funds/aozora-corporate-investment) — Series A
